Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antibiotic isolated and characterized at the Institute of Microbial Chemistry in Tokyo

Jan. 13, 1999

Nankai University team describes new compound with antileukemia activity

Jan. 13, 1999

Hybridon develops antisense oligonucleotides to thymidylate synthase

Jan. 13, 1999

Quinazolinones as farnesyltransferase inhibitors in early development at Janssen

Jan. 12, 1999

Spanish university research team discovers new alkaloids with antitumor properties

Jan. 12, 1999

IFN-gamma gene transfer to autologous melanoma tumor cells feasible, but further work needed

Jan. 11, 1999

Cell Pathways confirms novel mechanism of action of exisulind, CP-461 and related compounds

Jan. 11, 1999

Abgenix and AVI BioPharma to develop human antibody for cancer

Jan. 11, 1999

Ethyol for reducing radiation-induced xerostomia in head and neck cancer filed with FDA

Jan. 8, 1999

ProScript and NCI enter collaboration for development of anticancer therapeutic

Jan. 8, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...